Home
»
Amal Therapeutics
Skip to content
FinSMEs
REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS
Search for:
Facebook
Twitter
Linkedin
Navigation
Site navigation
USA
UK
Germany
France
Canada
India
Italy
Home
Amal Therapeutics
Amal Therapeutics
Germany
Switzerland
Boehringer Ingelheim Acquires Amal Therapeutics, For Up To €325M
Switzerland
Amal Therapeutics Closes €29M in Series B Funding
Switzerland
Amal Therapeutics Raises €8M in First Closing of Series B Funding Round
Switzerland
Amal Therapeutics Raises CHF3M in Series A Funding
funding
Germany
Start Up
Switzerland
venture capital
Amal Therapeutics Raises Seed Funding
Sign-up now to the Daily Newsletter